Search
for
Sort by
Research 151–180 of 1000+
- Quantification of the Vitamin D Receptor−Coregulator Interaction
- Use of Glucagon-Like Peptide-1 (GLP-1) Agonists in Modulating Preexisting Dermatologic Disease: A Systematic Review
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies
- Antidiabetic Management Strategies for Treatment of Polycystic Ovarian Syndrome
- Recommendations of endocrine treatment for patients with gender dysphoria
- Endocrinologia e Medicina Estética Ed. X
- Polymeric micelle mediated follicular delivery of spironolactone: Targeting the mineralocorticoid receptor to prevent glucocorticoid-induced activation and delayed cutaneous wound healing
- Mechanism of action of bolandiol (19-nortestosterone-3β,17β-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities
- Identification of xenobiotics interfering with 5 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="d1e152" altimg="si21.svg"> <mml:mi>α</mml:mi> </mml:math> -reductase (SRD5A2) activity
- The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
- Hormonal activity in commonly used Black hair care products: evaluating hormone disruption as a plausible contribution to health disparities
- Progressive expression of PPARGC1α is associated with hair miniaturization in androgenetic alopecia
- Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
- Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Rooster feathering, androgenic alopecia, and hormone-dependent tumor growth: What is in common?
- Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS
- Cellular actions of testosterone in vascular cells: Mechanism independent of aromatization to estradiol
- Redefining hormone resistance in prostate cancer
- Microarray analysis of androgenetic and senescent alopecia: Comparison of gene expression shows two distinct profiles
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- Hormonal regulation in male androgenetic alopecia—Sex hormones and beyond: Evidence from recent genetic studies
- Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review)
- Testosterone Prevents Cutaneous Ischemia and Necrosis in Males Through Complementary Estrogenic and Androgenic Actions
- Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues
- Gender-Difference in Hair Length as Revealed by Crispr-Based Production of Long-Haired Mice with Dysfunctional FGF5 Mutations
- 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy
- Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy
- Connarus semidecandrus Jack Exerts Anti-Alopecia Effects by Targeting 5α-Reductase Activity and an Intrinsic Apoptotic Pathway
- Antiandrogenic activity of Riboflavin 5′-phosphate (FMN) in 22Rv1 and LNCaP human prostate cancer cell lines